Harfst & Associates, Inc. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 124 filers reported holding SAGE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.96 and the average weighting 0.7%.

Quarter-by-quarter ownership
Harfst & Associates, Inc. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$2,0000.0%360.0%0.00%0.0%
Q1 2017$2,0000.0%360.0%0.00%0.0%
Q4 2015$2,0000.0%360.0%0.00%0.0%
Q3 2015$2,000
-33.3%
360.0%0.00%
-50.0%
Q2 2015$3,000360.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders